Leanne Kelly - Jun 2, 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Financial Officer
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
Jun 2, 2021
Transactions value $
$25,175
Form type
4
Date filed
6/4/2021, 04:06 PM
Previous filing
May 18, 2021
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRI Common Stock Purchase $14.6K +3.66K $4.00 3.66K Jun 2, 2021 Direct
transaction GRI Common Stock Purchase $4.39K +1.09K +29.67% $4.05 4.74K Jun 3, 2021 Direct
transaction GRI Common Stock Purchase $6.15K +1.51K +31.8% $4.08 6.25K Jun 4, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.